Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 12, 2021, after the close
10-Q filed Nov 12, 2021, 43 days after period end · 0000950170-21-004398
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | — | $2.50K | $2.50K | $2.50K |
| Net Income | $8.09M | -$1.84M | -$1.76M | -$1.83M |
| EPS Diluted | $0.42 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.66 |
| -$0.59 |
| -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
